|
|
News for Healthier Living
Precision STING delivery could help convert immune-desert tumors into inflamed tumors
A new review highlights the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway as a central switch that can convert immunologically "cold" tumors into "hot," inflamed tumors and improve immunotherapy responses. The authors synthesize how acute activation of this innate immune sensor promotes antigen presentation, T-cell priming, and type I interferon (IFN-I) signaling, while chronic or mistimed activation can drive immunosuppression, metastasis, and treatment resistance. The review maps next-generation STING-targeted agonists and delivery platforms--including antibody-drug conjugates (ADCs), immune-stimulating antibody conjugates (ISACs), nanoparticles, bacterial vectors, and exosomes--to distinct tumor microenvironment (TME) phenotypes. It proposes a strategic framework for rational combination therapies and biomarker-driven patient selection.
October 16, 2026
October 29 2026October 28 2026October 27 2026October 26 2026October 25 2026October 24 2026October 23 2026October 22 2026October 21 2026October 20 2026October 19 2026October 18 2026October 17 2026October 16 2026
|
|
|
|
|